Primary Research · 2008
Potential interaction of Ginkgo biloba leaf with antiplatelet or anticoagulant drugs: what is the evidence?
Bone · Mol Nutr Food Res, 2008
Key finding
Reviews multiple controlled studies showing ginkgo does NOT significantly impact hemostasis or aspirin/warfarin safety. Notes EGb 761 (standardized extract) is not generally implicated in case reports. Quality of published case reports is low. Mechanism (ginkgolide B as PAF antagonist) is real but clinically modest.
Read the paper
Open on PubMedhttps://pubmed.ncbi.nlm.nih.gov/18214851/
About this page
Formulate maintains a registry of clinical studies cited across its guides and evidence grades. This page links the study metadata to the content that cites it — one canonical entry per landmark study.
The full citation chain is public so readers can verify claims without hunting through individual guide pages. Browse all cited studies →
Note: Study summaries on this page are editorial interpretations of the research. Always consult the primary source before drawing clinical conclusions.